Clinical Trial Update: Liposomal Irinotecan + Oxaliplatin + Bevacizumab Versus Liposomal Irinotecan + 5-FU/LV [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating liposomal irinotecan with oxaliplatin and bevacizumab versus liposomal irinotecan with 5-FU/leucovorin in advanced pancreatic cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Bevacizumab (bevacizumab)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)
• Onivyde (irinotecan hydrochloride liposome injection)

Snippet

Sponsor: Dai, Guanghai | Conditions: Advanced Pancreatic Cancer (Part 1) | Phase 1, Phase 2 | Status: RECRUITING